These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4847907)

  • 21. Experimental models for the in vivo evaluation of enzyme induction properties of drugs.
    Bianchi C; Tomasi L; Bacci MC; Molino C; Bonardi G; Vidi A; Coppi G
    Arzneimittelforschung; 1973 Dec; 23(12):1681-9. PubMed ID: 4801679
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of fluorosteroids on drug response and metabolism.
    Kourounakis P; Szabo S; Selye H
    Biochem Pharmacol; 1976 Feb; 25(4):477-81. PubMed ID: 181004
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug metabolism and pharmacologic action in mice exposed to reduced barometric pressure.
    Medina MA; Merritt JH
    Biochem Pharmacol; 1970 Oct; 19(10):2812-6. PubMed ID: 5478590
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Half-life of hexobarbital and zoxazolamine in rodents. 2-In the rat].
    Buchel L; Absil J; Murawsky M
    C R Seances Soc Biol Fil; 1974; 168(2-3):265-70. PubMed ID: 4282286
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of 7 8-benzoflavone on the duration of zoxazolamine paralysis and hexobarbital hypnosis in rats.
    Wiebel FJ; Waters HL; Elliot S; Gelboin HV
    Biochem Pharmacol; 1976 Jun; 25(12):1431-2. PubMed ID: 938565
    [No Abstract]   [Full Text] [Related]  

  • 27. Massive liver enlargement accompanied by decreased drug metabolism. Effect of anterior pituitary extract on hepatic ultrastructure, zoxazolamine paralysis, and metabolism in the rat.
    Szabo S; Garg BD; Kourounakis P; Tuchweber B
    Can J Physiol Pharmacol; 1977 Oct; 55(5):1135-42. PubMed ID: 922587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity and metabolism of drugs in relation to dietary protein.
    Kato R; Oshima T; Tomizawa S
    Jpn J Pharmacol; 1968 Sep; 18(3):356-66. PubMed ID: 4387788
    [No Abstract]   [Full Text] [Related]  

  • 29. [A new biologic effect of certain aromatic polycyclic hydrocarbons and their heterocyclic analogs: inhibition of the hydroxylation of zoxazolamine in rats].
    Buu-Hoï NP; Do-Phuoc-Hien
    C R Acad Hebd Seances Acad Sci D; 1969 Jan; 268(2):423-6. PubMed ID: 4180256
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of metyrapone on drug metabolism and some other functions of the liver cell].
    Kahl GF; Magnussen MP; Netter KJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):225-6. PubMed ID: 5804253
    [No Abstract]   [Full Text] [Related]  

  • 31. Alteration of drug metabolism in rats and mice by an environment of cedarwood.
    Wade AE; Holl JE; Hilliard CC; Molton E; Greene FE
    Pharmacology; 1968 May; 1(5):317-28. PubMed ID: 4178661
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of endotoxin-tolerance on in vivo drug metabolism in mice.
    Abernathy CO; Zimmerman HJ; Utili R
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):193-6. PubMed ID: 7403675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the metabolism and pharmacology of alpha-((2-pyridylamino)methyl)benzyl alcohol hydrochloride (phenyramidol hydrochloride) in rodents.
    Gerber N; Seibert RA; Desiderio DM; Thompson RM
    Drug Metab Dispos; 1974; 2(2):140-7. PubMed ID: 4150994
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of ouabain and diphenylhydantoin on oxygen consumption in rats.
    Weinreich D; Karler R
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):330-9. PubMed ID: 5575587
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentiated anticonvulsant effect against and audiogenic seizure with frusemide and diphenylhydantoin sodium.
    Tongia SK
    Indian J Physiol Pharmacol; 1981; 25(3):292-4. PubMed ID: 7298157
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction and inhibition of hepatic drug metabolizing enzymes by rifampin.
    Pessayre D; Mazel P
    Biochem Pharmacol; 1976 Apr; 25(8):943-9. PubMed ID: 1267838
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of some stimulators (inducers) of hepatic microsomal drug-metabolizing enzyme activity on substrate-induced difference spectra in rat liver microsomes.
    Kutt H; Waters L; Fouts JR
    J Pharmacol Exp Ther; 1971 Oct; 179(1):101-13. PubMed ID: 5096561
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of adrenocorticotropic hormone, somatotrophic hormone and pregnenolone-16alpha-carbonitrile on drug response and metabolism.
    Szabo S; Kourounakis P; Selye H
    Biochem Pharmacol; 1975 Aug; 24(16):1549-51. PubMed ID: 172083
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro inhibition of drug metabolism by metabolites of progesterone.
    Soyka LF; Long RJ
    J Pharmacol Exp Ther; 1972 Aug; 182(2):320-7. PubMed ID: 5048367
    [No Abstract]   [Full Text] [Related]  

  • 40. Time course differences in the metabolism of drugs by hepatic microsomes from rats, rabbits and mice.
    Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1966 Jun; 152(3):363-71. PubMed ID: 5922307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.